Meng Qinghao, Hu Anna, Xiao Weiyu, Borris Robert P, Kim Hyun-Min
School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China.
Division of Natural and Applied Sciences, Duke Kunshan University, Kunshan 215316, China.
Pharmaceuticals (Basel). 2025 Jan 13;18(1):89. doi: 10.3390/ph18010089.
) is a plant with known medicinal properties, and its extracts have shown promise as potential anti-cancer agents. This study aimed to evaluate the nematocidal effects of L. patula extracts and investigate their impact on germline development, DNA damage responses, and apoptosis in ), a model organism for studying these processes.
was exposed to extracts to assess survival, development, and incidence of male phenotype. Germline abnormalities were examined using microscopy at different developmental stages. The DNA damage response was evaluated through the expression of the and . Apoptosis was quantified by monitoring cell death during the pachytene stage. LC-MS was used to identify bioactive compounds within the extracts.
Exposure to extracts resulted in a dose-dependent reduction in worm survival and larval developmental progress, with no significant impact on the male incidence. Germline defects were observed, including increased nuclear spacing at premeiotic and pachytene stages, altered number of bivalents during diakinesis. These defects correlated with a significant decrease in brood size. Also, extracts activated the DNA damage response pathway, marked by increased expression of and . Moreover, the extracts induced apoptosis in the germline in a pCHK-1-independent manner. LC-MS analysis revealed 31 potential anti-tumor compounds, supporting the extract's cytotoxic properties.
extracts exhibit potent nematocidal and cytotoxic properties, suggesting their potential for cancer therapy. The observed DNA damage and apoptosis in emphasize the extract's promising role in anti-cancer drug development. Further studies are needed to explore the therapeutic potential of these compounds in clinical settings.
[植物名称]是一种具有已知药用特性的植物,其提取物已显示出作为潜在抗癌剂的前景。本研究旨在评估[植物名称]提取物的杀线虫作用,并研究其对[线虫名称]生殖系发育、DNA损伤反应和细胞凋亡的影响,[线虫名称]是研究这些过程的模式生物。
将[线虫名称]暴露于[植物名称]提取物中,以评估其存活率、发育情况和雄性表型的发生率。在不同发育阶段使用显微镜检查生殖系异常情况。通过[基因名称1]和[基因名称2]的表达评估DNA损伤反应。通过监测粗线期的细胞死亡来量化细胞凋亡。使用液相色谱-质谱联用(LC-MS)鉴定提取物中的生物活性化合物。
暴露于[植物名称]提取物导致线虫存活率和幼虫发育进程呈剂量依赖性降低,对雄性发生率无显著影响。观察到生殖系缺陷,包括减数分裂前期和粗线期核间距增加、终变期二价体数量改变。这些缺陷与产卵量显著减少相关。此外,[植物名称]提取物激活了DNA损伤反应途径,表现为[基因名称1]和[基因名称2]表达增加。此外,提取物以不依赖pCHK-1的方式诱导生殖系细胞凋亡。LC-MS分析揭示了31种潜在的抗肿瘤化合物,支持了提取物的细胞毒性特性。
[植物名称]提取物具有强大的杀线虫和细胞毒性特性,表明其在癌症治疗中的潜力。在[线虫名称]中观察到的DNA损伤和细胞凋亡强调了提取物在抗癌药物开发中的潜在作用。需要进一步研究以探索这些化合物在临床环境中的治疗潜力。